Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease

American Journal of Nephrology

Volumn 41, Issue , 2015, Pages 456-463

  Nakhoul, Georges N ^a   Huang, Haiquan ^a,c   Arrigain, Susana ^a   Jolly, Stacey E ^a,b   Schold, Jesse D ^a   Nally Jr , Joseph V ^a,b   Navaneethan, Sankar D ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c SOUTHEAST UNIVERSITY   (China)

Author keywords

Chronic kidney disease; End stage renal disease and mortality; Mortality; Potassium

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM;

AFRICAN AMERICAN; AGE; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; END STAGE RENAL DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE SYSTEM; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPOKALEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; BLOOD; CHRONIC KIDNEY FAILURE; ETHNOLOGY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; REGISTER; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; HYPERKALEMIA; HYPOKALEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POTASSIUM; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84939527846     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000437151     Document Type: Article

References (35)

1. Stanton BA: Renal potassium transport: morphological and functional adaptations. Am J Physiol 1989; 257(5 pt 2):R989-R997.
2. Gonick HC, Kleeman CR, Rubini ME, Maxwell MH: Functional impairment in chronic renal disease. 3. Studies of potassium excretion. Am J Med Sci 1971; 261: 281-290.
3. Palmer BF: Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med 2004; 351: 585-592.
4. Genovesi S, Valsecchi MG, Rossi E, Pogliani D, Acquistapace I, De Cristofaro V, et al: Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrol Dial Transplant 2009; 24: 2529-2536.
5. Unruh ML, Evans IV, Fink NE, Powe NR, Meyer KB; Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study: Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients. Am J Kidney Dis 2005; 46: 1107-1116.
6. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482.
7. Hayes J, Kalantar-Zadeh K, Lu JL, Turban S, Anderson JE, Kovesdy CP: Association of hypo-and hyperkalemia with disease progression and mortality in males with chronic kidney disease: The role of race. Nephron Clin Pract 2012; 120:c8-c16.
8. Korgaonkar S, Tilea A, Gillespie BW, Kiser M, Eisele G, Finkelstein F, et al: Serum potassium and outcomes in CKD: insights from the RRICKD cohort study. Clin J Am Soc Nephrol 2010; 5: 762-769.
9. Sinha AD, Agarwal R: Chronic renal disease progression: Treatment strategies and potassium intake. Semin Nephrol 2013; 33: 290-299.
10. Weir MR, Fink JC: Salt intake and progression of chronic kidney disease: An overlooked modifiable exposure? A commentary. Am J Kidney Dis 2005; 45: 176-188.
11. Wang W, Soltero L, Zhang P, Huang XR, Lan HY, Adrogue HJ: Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7. Am J Physiol Renal Physiol 2007; 293:F1123-F1130.
12. Reungjui S, Roncal CA, Sato W, Glushakova OY, Croker BP, Suga S, et al: Hypokalemic nephropathy is associated with impaired angiogenesis. J Am Soc Nephrol 2008; 19: 125-134.
13. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Saupe W, Sharp J, et al: Development and validation of an electronic health recordbased chronic kidney disease registry. Clin J Am Soc Nephrol 2011; 6: 40-49.
14. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
15. Moranne O, Froissart M, Rossert J, Gauci C, Boffa JJ, Haymann JP, et al. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol 2009; 20: 164-171.
16. Perez GO, Pelleya R, Oster JR, Kem DC, Vaamonde CA: Blunted kaliuresis after an acute potassium load in patients with chronic renal failure. Kidney Int 1983; 24: 656-662.
17. Kraft MD, Btaiche IF, Sacks GS, Kudsk KA: Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health Syst Pharm 2005; 62: 1663-1682.
18. Williams ME: Endocrine crises. Hyperkalemia. Crit Care Clin 1991; 7: 155-174.
19. Seliger SL, Zhan M, Hsu VD, Walker LD, Fink JC: Chronic kidney disease adversely influences patient safety. J Am Soc Nephrol 2008; 19: 2414-2419.
20. Reardon LC, Macpherson DS: Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? Arch Intern Med 1998; 158: 26-32.
21. Tannen RL: Diuretic-induced hypokalemia. Kidney Int 1985; 28: 988-1000.
22. Berenson GS, Voors AW, Dalferes ER Jr, Webber LS, Shuler SE: Creatinine clearance, electrolytes, and plasma renin activity related to the blood pressure of white and black children-the Bogalusa heart study. J Lab Clin Med 1979; 93: 535-548.
23. Lasker N, Hopp L, Grossman S, Bamforth R, Aviv A: Race and sex differences in erythrocyte Na+, K+, and Na+-K+-adenosine triphosphatase. J Clin Invest 1985; 75: 1813-1820.
24. Gallen IW, Rosa RM, Esparaz DY, Young JB, Robertson GL, Batlle D, et al: On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention. Am J Kidney Dis 1998; 31: 19-27.
25. Voors AW, Dalferes ER Jr, Frank GC, Aristimuno GG, Berenson GS: Relation between ingested potassium and sodium balance in young blacks and whites. Am J Clin Nutr 1983; 37: 583-594.
26. Ahmed A, Zannad F, Love TE, Tallaj J, Gheorghiade M, Ekundayo OJ, et al: A propensitymatched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 2007; 28: 1334-1343.
27. Hunt SA; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005; 46:e1-e82.
28. Bowling CB, Pitt B, Ahmed MI, Aban IB, Sanders PW, Mujib M, et al: Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies. Circ Heart Fail 2010; 3: 253-260.
29. Schulman M, Narins RG: Hypokalemia and cardiovascular disease. Am J Cardiol 1990; 65: 4E-9E; discussion 22E-23E.
30. Erlinger TP, Tarver-Carr ME, Powe NR, Appel LJ, Coresh J, Eberhardt MS, et al: Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults. Am J Kidney Dis 2003; 42: 256-263.
31. Einhorn LM, Zhan M, Hsu VD, Walker LD, Moen MF, Seliger SL, et al: The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 2009; 169: 1156-1162.
32. Surawicz B, Chlebus H, Mazzoleni A: Hemodynamic and electrocardiographic effects of hyperpotassemia. Differences in response to slow and rapid increases in concentration of plasma K. Am Heart J 1967; 73: 647-664.
33. Elger M, Bankir L, Kriz W: Morphometric analysis of kidney hypertrophy in rats after chronic potassium depletion. Am J Physiol 1992; 262(4 pt 2):F656-F667.
34. Ray PE, Suga S, Liu XH, Huang X, Johnson RJ: Chronic potassium depletion induces renal injury, salt sensitivity, and hypertension in young rats. Kidney Int 2001; 59: 1850-1858.
35. Drawz PE, Goswami P, Azem R, Babineau DC, Rahman M: A simple tool to predict endstage renal disease within 1 year in elderly adults with advanced chronic kidney disease. J Am Geriatr Soc 2013; 61: 762-768.